To further investigate the impact of Gal-9 on the lysosomal-autophagosomal pathway, protein levels of LAMP-2, p62, LC3B-I and LC3B-II were determined in DLBCL cells upon treatment with Gal-9. This evidence concerns the gene SQSTM1 and diffuse large B-cell lymphoma.